U.S. Food and Staples Retail Stock News

Earlier in June, Celldex Therapeutics reported at the European Academy of Allergy and Clinical Immunology meeting that barzolvolimab produced rapid, durable and off-treatment improvements in angioedema for chronic spontaneous urticaria patients in Phase 2, while CDX-622 Phase 1 data in healthy participants showed dose-dependent mast cell depletion with a favorable safety profile. The combination of prolonged angioedema control seven months after barzolvolimab dosing and CDX-622’s...

Corcept Therapeutics has resubmitted its New Drug Application to the FDA for relacorilant in Cushing’s syndrome, incorporating additional analyses of existing clinical data as requested by regulators, with the company indicating it expects a six‑month review period. This resubmission leans heavily on positive results from the pivotal GRACE trial, the placebo‑controlled Phase III GRADIENT trial, and long‑term extension data, highlighting relacorilant’s central role in Corcept’s...

Recently, F.N.B. Corporation announced that CEO Vincent Delie received two national leadership awards, while the company and its main banking subsidiary were named to Business Insider’s inaugural America’s High Growth Companies 2026 list. Together, these honors spotlight F.N.B.’s emphasis on disciplined expansion, digital innovation and workplace culture as key drivers of its recognized business success. We’ll now examine how this national recognition for disciplined growth and leadership...

If you are trying to figure out whether SLB stock offers value at its recent price, this article walks through what that current valuation really means for you. SLB last closed at US$47.42, with the stock down 1.4% over the past week and 18.2% over the past month, while still showing a 44.0% return over the last year and 18.0% year to date. Recent SLB headlines have focused on how the company is positioned within the energy services sector and what that might mean for future projects and...

Cadence Design Systems (CDNS) has drawn investor attention after a recent pullback, with the stock down 1.1% over the past day and 4.9% over the past week. This has prompted a closer look at its fundamentals. See our latest analysis for Cadence Design Systems. Beyond the recent pullback, Cadence Design Systems has a 90 day share price return of 35.49% and a year to date share price return of 18.63%. The 5 year total shareholder return of 168.92% reflects a strong longer term record despite...

Tech stocks are under pressure after sharp sell offs in Asia and fresh worries about how higher device and AI costs will hit consumers. For many investors, this is a prompt to revisit the role of Consumer Staples stocks, where demand can sometimes be steadier when people cut back elsewhere. This article looks at three larger Consumer Staples companies from a recent screener that appear especially exposed to the latest tech related news, and explores how that backdrop might influence their...

eBay stock performance snapshot eBay (EBAY) has drawn investor attention after recent trading, with the stock last closing at $108. Over the past month the share price declined about 6%, while the past 3 months show a gain of around 23%. See our latest analysis for eBay. Looking beyond the latest pullback, eBay’s 30 day share price return of down 6.3% contrasts with a stronger 90 day share price return of 22.8%. Meanwhile, the 1 year total shareholder return of 48.5% suggests momentum has...

With inflation, interest rates and growth signals pulling in different directions across the US, Europe and Asia, many investors are looking for leaders with real skin in the game rather than hired managers on short contracts. Founder led companies can be especially interesting here, because the same people who built the business still set the tone on capital allocation and long term decisions. This Top Founder Led Companies screener focuses on capital efficiency and ownership so you can...

Recent Performance Context For Andersons Stock Andersons (ANDE) stock has drawn attention after a strong year to date return of 34.1%, alongside a 1 year total return of 97.2% and a 3 year total return of 63.3%. Over the past month, the stock has been broadly flat, while the past 3 months show a decline of 2.8%. The most recent close was US$71.15, giving Andersons an equity value of about US$2.38b. See our latest analysis for Andersons. The recent share price pullback over the past quarter...

Peace signals between the U.S. and Iran, extra IAEA oversight, and a toll free reopening of the Strait of Hormuz have shifted attention back to how quickly risk premiums can change in global energy markets. For investors watching large, financially solid oil and gas stocks in the U.S., UK, Canada, and Australia, this mix of easing tensions and lingering uncertainty could reshape how certain companies are priced. This article looks at 3 stocks from the Global Energy Sector screener that appear...

Snowflake (SNOW) is back in focus after a string of June announcements, as new client wins on its AI Data Cloud and fresh partner recognition appear to tie into the stock’s sharp recent move. See our latest analysis for Snowflake. Snowflake’s recent client wins and partner recognition arrive after a volatile stretch, with the share price rebounding to $227.06 and posting a 30 day share price return of 27.85%. The 1 year total shareholder return is 2.32% and the 3 year total shareholder return...

Earlier this month, Illinois Governor J.B. Pritzker announced that Archer-Daniels-Midland will invest US$103,000,000 to modernize its Decatur corn and soybean processing complex, adding 50 new full-time roles while retaining more than 1,000 existing jobs. By upgrading aging control systems at one of the world’s largest integrated agricultural processing hubs, ADM is tying local job stability to a long-term shift toward more advanced ag tech and food processing capabilities. We’ll now examine...

Strategy (MSTR) has drawn attention after its stock declined sharply over the past month and past 3 months, prompting investors to reassess how its bitcoin treasury focus and AI analytics software fit into broader portfolios. See our latest analysis for Strategy. Over the past year, Strategy’s share price has retreated sharply, with a 1 day share price return of down 9.35% and a 30 day share price return of down 46.65%, while the 3 year total shareholder return of 150.78% still reflects...

If you are wondering whether New York Times stock still offers fair value after a strong run, the current setup makes it an interesting case to examine more closely. The share price closed at US$68.57, with the stock down 6.1% over the past week and 8.6% over the past month, while still up 24.2% over the last year and 78.8% over three years. These moves sit against a backdrop of ongoing interest in New York Times as a pure play on digital and subscription led media. Investors regularly...

Earlier this year, Trane Technologies was named to TIME’s 2026 list of the World’s Most Sustainable Companies, ranking 19th, and again earned sustainability leadership recognitions from the Financial Times and CDP. These repeated accolades highlight measurable progress in emissions reductions, energy efficiency, circularity, workforce development, and community impact, reinforcing Trane’s positioning with investors focused on ESG performance. We’ll now examine how this global recognition for...

Century Communities, Inc. has recently expanded its footprint with new single-family home communities, including Echo Grove in Georgia, The Preserve in Colorado, Evelyn in Texas, and Cedar Hollow in North Carolina, offering ranch and two-story homes across diverse price points, lot sizes, and amenity-rich locations. An interesting angle for investors is how these launches span both entry-level and higher-end “Signature Collection” offerings, potentially broadening Century Communities’...

Florida Attorney General has opened an investigation into CVS Health’s Caremark unit for alleged anticompetitive practices affecting independent pharmacies. The probe focuses on claims of steering patients to CVS-owned pharmacies, preferential reimbursement rates, and audit practices that may disadvantage competitors. This state-level action adds to broader scrutiny of pharmacy benefit managers and raises potential regulatory and reputational questions for NYSE:CVS. CVS Health, trading on...

Wondering whether Alexandria Real Estate Equities is priced attractively today, or if the stock's story is already in the price? This article focuses squarely on what the current share price may be implying about value. Alexandria Real Estate Equities recently closed at US$53.29, with returns of 4.4% over the past week, 9.9% over the last month and 8.8% year to date. The stock is still down 23.4% over one year and 45.6% over three years. Those mixed returns come alongside ongoing investor...

Everpure (P) has recently attracted investor attention after a period in which the stock declined about 19% over the past month but gained roughly 22% over the past 3 months, highlighting shifting sentiment around its data storage business. See our latest analysis for Everpure. Set against this recent pullback, Everpure’s share price has a year to date return of 3.88%, while the 1 year total shareholder return of 28.89% points to longer term momentum still in place. If you are looking beyond...

In June 2026, Tradeweb Markets Inc. launched several new tools for institutional clients, including TARA, an AI-powered research assistant for U.S. credit, electronic spread trading for European credit bond portfolios, and a dedicated Kalshi pricing page that embeds event contract data and market‑implied probabilities directly into trading workflows. Together, these product launches deepen Tradeweb’s role as a data and workflow hub, potentially increasing client reliance on its platform for...

In June 2026, Bath & Body Works announced a partnership with Ulta Beauty to sell a curated range of its body care and home fragrance products in more than 600 Ulta stores and on Ulta.com, starting July 12, 2026. The collaboration extends Bath & Body Works’ marketplace push, adding Ulta as a major beauty channel partner and using exclusives like the Juniper Breeze revival to spark discovery among new shoppers. We’ll now examine how this expanded Ulta distribution, including exclusive...

If you are trying to work out whether American Airlines Group stock offers value at its recent US$17.57 close, the starting point is understanding how its current price lines up with different valuation methods. The stock has seen sharp moves recently, with returns of 9.9% over 7 days, 18.4% over 30 days, 13.5% year to date and 57.9% over 1 year. The 3 year and 5 year returns are essentially flat at a 0.2% decline and an 18.3% decline, respectively. Recent coverage of American Airlines Group...

Krystal Biotech (KRYS) has drawn fresh attention after recent trading left the stock with a 1 day move of 3.5% and a past 3 months return of 46.7%. This has prompted closer scrutiny of fundamentals. See our latest analysis for Krystal Biotech. At a latest share price of $359.93, Krystal Biotech shows strong momentum, with a 30 day share price return of 18.9% and a 1 year total shareholder return of 152.4%, pointing to growing investor interest. If this kind of momentum has your attention, it...

If you are wondering whether Applied Optoelectronics is still good value after a strong run, the next sections break down what the current price might be implying about the stock. The share price closed at US$138.54, with the stock down 14.4% over the last week and 22.0% over the last month, yet still up 249.8% year to date and 398.9% over the past year. This combination of short-term declines and longer-term gains can change how you think about both risk and potential. These sharp moves...